Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection.
Arca-Suárez J, Vázquez-Ucha JC, Fraile-Ribot PA, Lence E, Cabot G, Martínez-Guitián M, Lasarte-Monterrubio C, Rodríguez-Iglesias M, Beceiro A, González-Bello C, Galán-Sánchez F, Oliver A, Bou G. Arca-Suárez J, et al. J Antimicrob Chemother. 2020 Nov 1;75(11):3209-3217. doi: 10.1093/jac/dkaa291. J Antimicrob Chemother. 2020. PMID: 32728723
Syzygium aromaticum (clove) and Thymus zygis (thyme) essential oils increase susceptibility to colistin in the nosocomial pathogens Acinetobacter baumannii and Klebsiella pneumoniae.
Vázquez-Ucha JC, Martínez-Guitián M, Lasarte-Monterrubio C, Conde-Pérez K, Arca-Suárez J, Álvarez-Fraga L, Pérez A, Crecente-Campo J, Alonso MJ, Bou G, Poza M, Beceiro A. Vázquez-Ucha JC, et al. Biomed Pharmacother. 2020 Oct;130:110606. doi: 10.1016/j.biopha.2020.110606. Epub 2020 Aug 11. Biomed Pharmacother. 2020. PMID: 32795924 Free article.
Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections.
Arca-Suárez J, Lasarte-Monterrubio C, Rodiño-Janeiro BK, Cabot G, Vázquez-Ucha JC, Rodríguez-Iglesias M, Galán-Sánchez F, Beceiro A, González-Bello C, Oliver A, Bou G. Arca-Suárez J, et al. J Antimicrob Chemother. 2021 Jan 1;76(1):91-100. doi: 10.1093/jac/dkaa396. J Antimicrob Chemother. 2021. PMID: 33083833
Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales.
Vázquez-Ucha JC, Seoane-Estévez A, Rodiño-Janeiro BK, González-Bardanca M, Conde-Pérez K, Martínez-Guitián M, Alvarez-Fraga L, Arca-Suárez J, Lasarte-Monterrubio C, Gut M, Gut I, Álvarez-Tejado M, Oviaño M, Beceiro A, Bou G; GEMARA-SEIMC/REIPI Enterobacterales Study Group. Vázquez-Ucha JC, et al. J Antimicrob Chemother. 2021 May 12;76(6):1498-1510. doi: 10.1093/jac/dkab043. J Antimicrob Chemother. 2021. PMID: 33677560
6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to β-Lactam Antibiotics.
Vázquez-Ucha JC, Rodríguez D, Lasarte-Monterrubio C, Lence E, Arca-Suarez J, Maneiro M, Gato E, Perez A, Martínez-Guitián M, Juan C, Oliver A, Bou G, González-Bello C, Beceiro A. Vázquez-Ucha JC, et al. J Med Chem. 2021 May 13;64(9):6310-6328. doi: 10.1021/acs.jmedchem.1c00369. Epub 2021 Apr 29. J Med Chem. 2021. PMID: 33913328
Assessment of Activity and Resistance Mechanisms to Cefepime in Combination with the Novel β-Lactamase Inhibitors Zidebactam, Taniborbactam, and Enmetazobactam against a Multicenter Collection of Carbapenemase-Producing Enterobacterales.
Vázquez-Ucha JC, Lasarte-Monterrubio C, Guijarro-Sánchez P, Oviaño M, Álvarez-Fraga L, Alonso-García I, Arca-Suárez J, Bou G, Beceiro A; GEMARA-SEIMC/REIPI Enterobacterales Study Group. Vázquez-Ucha JC, et al. Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0167621. doi: 10.1128/AAC.01676-21. Epub 2021 Nov 22. Antimicrob Agents Chemother. 2022. PMID: 34807754 Free PMC article.
21 results